In regard to molecular subtypes and tumor stages, 46% were lumina A, 18% luminal B, 7% Her2-enriched, 16% basal-like and 3% normal-like, whereas 17% were tumor stage 1 (T1), 58% T2 stage, 23% T3 stage and 2% T4 stage (Supplementary Table S1). The gene discussed is ERBB2; the disease is neoplasm.